C12Q 1/702
For retroviruses
Official title: {for retroviruses}
C12Q1/702 (For retroviruses) appears on 828 US grants and 841 published applications in this corpus.
Search patents in C12Q- Granted patents
- 828
- Published applications
- 841
- Assignees
- 509
- Inventors
- 1,778
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 6 | 0 |
| 1992 | 14 | 0 |
| 1993 | 13 | 0 |
| 1994 | 8 | 0 |
| 1995 | 17 | 0 |
| 1996 | 35 | 0 |
| 1997 | 41 | 0 |
| 1998 | 47 | 0 |
| 1999 | 37 | 0 |
| 2000 | 35 | 0 |
| 2001 | 37 | 12 |
| 2002 | 32 | 47 |
| 2003 | 41 | 58 |
| 2004 | 24 | 51 |
| 2005 | 23 | 53 |
| 2006 | 20 | 41 |
| 2007 | 26 | 36 |
| 2008 | 21 | 27 |
| 2009 | 23 | 39 |
| 2010 | 25 | 43 |
| 2011 | 15 | 32 |
| 2012 | 22 | 37 |
| 2013 | 12 | 22 |
| 2014 | 19 | 34 |
| 2015 | 21 | 50 |
| 2016 | 23 | 35 |
| 2017 | 17 | 35 |
| 2018 | 33 | 28 |
| 2019 | 38 | 31 |
| 2020 | 19 | 29 |
| 2021 | 19 | 22 |
| 2022 | 20 | 20 |
| 2023 | 8 | 20 |
| 2024 | 7 | 13 |
| 2025 | 13 | 17 |
| 2026 | 8 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- HIV viral load testing29 Sep 2026US 12,748,120 B2Diagnostics for the Real World, Ltd.
- Method for determining titer of RNA viral vectors22 Sep 2026US 12,742,216 B2Abelzeta Inc.
- Compositions and methods for quantifying integration of recombinant vector nucleic acid7 Jul 2026US 12,674,213 B2Janssen Biotech, Inc.
- HIV-1 eradication strategy employing nanoformulated anti-retroviral drugs and gene editing agents2 Jun 2026US 12,644,121 B2Board of Regents of the University of Nebraska
- FRET-based analytes detection and related methods and systems10 Mar 2026US 12,571,048 B2California Institute of Technology
- Fret-based analytes detection and related methods and systems1 Oct 2026US 2026/0297675 A1California Institute of Technology
- Digital droplet based assay for detecting replication competent lentiviral vector1 Oct 2026US 2026/0297693 A1Sana Biotechnology, Inc.
- Target reporter constructs and uses thereof27 Aug 2026US 2026/0250742 A1RedVault Biosciences, LP
- Programmable rna detection using pseudo-guide dna using cas12i and cas12a20 Aug 2026US 2026/0242852 A1
- Methylation signatures of pathogen and chemical exposures in human cells20 Aug 2026US 2026/0242881 A1The Salk Institute for Biological Studies
Most cited
By later US patents
- Homogeneous assay system using the nuclease activity of a nucleic acid polymerase907US 5,210,015 AHoffman-La Roche Inc. · 1993
- Homogeneous methods for nucleic acid amplification and detection623US 5,994,056 ARoche Molecular Systems, Inc. · 1999
- Nucleic acid amplification process577US 5,409,818 ACangene Corporation · 1995
- Nucleic acid detection by the 5'-3'exonuclease activity of polymerases acting on adjacently hybridized oligonucleotides361US 5,487,972 AHoffmann-La Roche Inc. · 1996
- Amplification of target nucleic acids using gap filling ligase chain reaction351US 5,427,930 AAbbott Laboratories · 1995